Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$32.73 - $47.95 $65,165 - $95,468
-1,991 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$40.39 - $56.73 $40 - $56
-1 Reduced 0.05%
1,991 $69,000
Q4 2020

Jan 13, 2021

BUY
$51.77 - $66.18 $15,272 - $19,523
295 Added 17.38%
1,992 $114,000
Q3 2020

Nov 12, 2020

SELL
$43.8 - $58.16 $44,281 - $58,799
-1,011 Reduced 37.33%
1,697 $87,000
Q2 2020

Aug 13, 2020

BUY
$37.05 - $65.03 $94,588 - $166,021
2,553 Added 1647.1%
2,708 $162,000
Q1 2020

May 12, 2020

SELL
$33.63 - $69.4 $29,661 - $61,210
-882 Reduced 85.05%
155 $6,000
Q4 2019

Feb 07, 2020

BUY
$31.7 - $69.93 $32,872 - $72,517
1,037 New
1,037 $64,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.